Stockwinners Market Radar for February 16, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:18 EST Cathie Wood's ARK Investment bought 455K shares of Roblox today

20:03 EST Group 1 Automotive raises quarterly dividend to 36c from 35c per share - The dividend is payable on March 15, 2022, to stockholders of record as of March 1, 2022.

18:33 EST Moderna: TGA in Australia authorizes Covid-19 vaccine in children aged 6-11 - Moderna announced that the Therapeutic Goods Administration in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50 microgram dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years.

18:11 EST American Campus says Land & Buildings indicated willingness for takeover bid - American Campus Communities released the following statement pertaining to its relationship with Land & Buildings: "Most recently, on February 15, 2022, ACC received a letter from Land & Buildings in which the hedge fund does not propose to acquire ACC, but claims that it is "indicating its willingness to offer to acquire" ACC for $57.00 per share, below the Company's recent all-time high of $57.29. Land & Buildings' actions to date, its inability to finance or consummate a transaction, and its use of this same "faux bid" tactic on at least two prior occasions in efforts to force the sales of other companies, highlight the fact that Land & Buildings is not a credible potential buyer of ACC. ACC's Board is resolute in its commitment to acting in the best interest of shareholders, and would always consider and respond to a bona fide, actionable proposal from a credible potential counterparty that maximizes value for shareholders. The Company has engaged with Land & Buildings in good faith for more than a year, and had hoped to again avoid the expense and unnecessary distraction of a contested director election by reaching a mutually acceptable resolution. To be clear, however, ACC does not believe it is in the best interests of all other shareholders to appoint Mr. Lorinsky as a director. Accordingly, while the Company and its advisors will continue to engage with Land & Buildings and encourage them to withdraw Mr. Lorinsky's nomination, at this time ACC is preparing for the costly and distracting proxy contest that Land & Buildings initiated. ACC is a strong company, with a uniquely valuable portfolio, talented employees and diversified sources of capital. We have successfully navigated through the disruption of the COVID-19 pandemic and believe we are now poised to benefit from recent initiatives and the positive fundamentals of the student housing operating environment to deliver recession resilient, robust organic growth, meaningful earnings growth and substantial net asset value creation to investors. The Board and management team believe it is an exciting time to own ACC and we are confident in the Company's future prospects. We look forward to continued engagement with our shareholders as we build on our momentum." The company added that its board determined that Corey Lorinsky, Land & Buildings' director nomination, would not be an additive member to the board.

18:04 EST Amazon Web Services announces global expansion of AWS Local Zones - Amazon Web Services announced the completion of its first 16 AWS Local Zones in the U.S. and plans to launch new AWS Local Zones in 32 new metropolitan areas in 26 countries around the world. AWS Local Zones are a type of infrastructure deployment that extends AWS Regions to place compute, storage, database, and other AWS services at the edge of the cloud near large population, industry, and information technology (IT) centers-enabling customers to deploy applications that require single-digit millisecond latency closer to end users or on-premises data centers. AWS Local Zones allow customers to use core AWS services locally while seamlessly connecting to the rest of their workloads running in AWS Regions with the same elasticity, pay-as-you-go model, application programming interfaces (APIs), and toolsets.

17:42 EST Ottawa Bancorp raises quarterly dividend to 11c from 10c per share - The increased quarterly cash dividend will be paid on or about March 16, 2022, to stockholders of record as of the close of business on March 2, 2022.

17:36 EST Nutrien increases dividend 4% to 48c per share - Nutrien declared a quarterly dividend of 48c per share payable on April 14 to shareholders of record on March 31. This represents a 4% increase from the prior dividend declared on November 1, 2021 and equates to an annualized dividend of $1.92 per share.

17:20 EST NVR authorizes $500M share repurchase - NVR has authorized the repurchase of $500M of its outstanding common stock. The authorization is a continuation of the stock repurchase program that began in 1994. As of February 15, NVR had 3,378,726 total shares of common stock outstanding.

17:07 EST Kinross Gold sees 2022 attributable production 2.65 million Au eq. oz. - Kinross Gold sees 2022 attributable production of 2.65 million attributable Au eq. oz., +/- 5%. from its operations, a 28% increase from the company's 2021 production. Kinross' annual production is expected to further increase to 2.8 million attributable Au eq. oz. +/- 5% in 2023. The company expects to produce 2.6 million attributable Au eq. oz. in 2024.

17:01 EST Home Federal Bancorp announces new stock repurchase program - Home Federal Bancorp announced that its Board of Directors on February 16, approved the company's eleventh stock repurchase program. The new repurchase program provides for the repurchase of up to 170,000 shares, or approximately 5.0% of the company's outstanding common stock from time to time, in open market or privately negotiated transactions. The stock repurchase program does not have an expiration date.

16:49 EST Waste Connections sees FY22 adjusted free cash flow $1.15B - Sees FY22 CapEx about $850M, including $100M for new landfill gas and resource recovery facilities.

16:47 EST Saint Joe Co., Electric Cart announce joint venture for golf cart and LSV sales - Saint Joe Co. and Electric Cart announced a joint venture to bring golf cart and low speed vehicle, or LSV, sales to two of St. Joe's lifestyle shopping centers. Plans call for a sales and service location at Watersound West Bay Center adjacent to the Latitude Margaritaville Watersound community in Panama City Beach, Florida and a sales showroom at Watersound Town Center in Santa Rosa Beach, Florida. An approximately 11,000-square-foot full-service dealership is planned for Watersound West Bay Center offering sales and service of golf carts and LSVs. This lifestyle shopping center is being constructed adjacent to the Latitude Margaritaville Watersound community. This active-adult community, which welcomed its first residents in late 2021, is planned for 3,500 homes with multimodal connectivity to Watersound West Bay Center. At Watersound Town Center, located at the entrance to the master planned Watersound Origins community, plans include a sales showroom. Both locations plan to offer a wide variety of golf carts and LSVs from manufacturers such as Club Car, Evolutions, Garia, GEM, Pilotcar EV, Moke of America, Star EV, Tomberlin and Yamaha, among others. The companies intend to open the Watersound West Bay Center dealership later in 2022 and the Watersound Town Center showroom in 2023.

16:42 EST Realogy names Melissa McSherry as COO, effective February 22 - Realogy (RLGY) announced the appointment of Melissa McSherry as COO, effective February 22. Reporting to Realogy President and CEO, Ryan Schneider, McSherry will serve as a member of the company's executive leadership team, driving product, technology, enterprise marketing, and customer experience. Over her nearly 30-year career, McSherry has held senior product, technology, data, and strategy roles at multiple largescale, high-performing organizations, most recently serving as Senior Vice President at Visa (V).

16:41 EST Marin Software announces TikTok integration - Marin Software announced the ability to optimize TikTok ad campaigns through its flagship MarinOne platform. The integration with TikTok's Ad Manager gives advertisers better insights and improves the performance of their TikTok campaigns through machine learning and automation. The self-serve MarinOne platform unifies industry-leading optimization tools and AI bidding with flexible reporting to help advertisers maximize the reach and impact of their TikTok marketing investment.

16:39 EST Hershey purchases stock from Hershey Trust Company - The Hershey Company announced that it has completed a purchase of 1M shares of its common stock from Hershey Trust Company, as Trustee for the Milton Hershey School Trust, for approximately $203M, or $203.35 per share.

16:38 EST Safe Bulkers says assessing the use of biofuels as alternative fuels - Safe Bulkers announced that in the framework of several environmental initiatives targeting to reduce its carbon footprint, it is assessing the use of biofuels as alternative fuels. A number of pilot projects have been designed to test the operational performance and the interaction of biofuels with the vessel's main engine and diesel generators operations and assess the CO2 emissions reduction. The first pilot project was carried out in M/V Troodos Oak which received 346 metric tonnes of Bio-Fuel blend B20, consisting of 20% Spent Bleaching Earth Oil mixed with conventional Very Low Sulphur Fuel Oil . The project was performed in cooperation with vessel's charterer Cargill, Cargill Marine Fuels and Oilchart as suppliers of the blended bio bunkers, the vessel's classification society Lloyds Register and Cyprus Flag. The trial followed the guidelines of EU's Renewable Energy Directive "RED II" on calculating CO2 emissions. The trials resulted in a 13.54% CO2 equivalent reduction compared to conventional VLSFO. No modification to existing ship equipment was required. No operational abnormalities or wear have been observed in main engine and diesel generators. For the purpose of CO2 emissions reporting schemes, European Union - MRV scheme and International Maritime Organization DCS scheme, the reported CO2 emissions as verified by LR and accepted by Cyprus Flag are by 20% lower compared to the VLSFO. The Company will continue to explore potential use of biofuel blends in its decarbonization alternatives by further expanding the project with its partner Cargill, to include additional vessels and higher biofuel blends, measuring in addition the nitrogen oxide emissions. Dr. Loukas Barmparis, President of the Company, commented: "The successful pilot project that we have completed with Cargill is encouraging for the use of biofuels as alternative fuels. We will continue to assess their use in parallel to other available technologies targeting to optimize our operations and improve our environmental footprint.''

16:37 EST Neenah sees 'continued robust revenue' in 2022 - In 2022, the company expects: "Continued robust revenue growth driven by increasing volumes in our four growth platforms; Benefits from pricing and other actions to address inflationary pressures across all lines of business; Input costs to remain at elevated levels; year-on-year comparison most acute in first half of 2022; Challenging supply chain and US labor cost and availability environment."

16:35 EST Healthcare Realty Trust boosts quarterly dividend to31c per share - Healthcare Realty Trust announced its common stock cash dividend in the amount of 31c per share, payable on March 15, 2022 to stockholders of record on February 28, 2022. This dividend amount reflects an increase from $0.3025 per share previously.

16:34 EST Host Hotels reinstates quarterly cash dividend of 3c per share - The Board of Directors announced a regular quarterly cash dividend of 3c on its common stock. The dividend will be paid on April 15 to stockholders of record on March 31. All future dividends are subject to approval by the Company's board.

16:32 EST EnPro raises quarterly dividend to 28c to 27c per share - The dividend is payable on March 16, 2022 to shareholders of record as of the close of business on March 2, 2022. "The decision to increase our quarterly dividend signals a continuation of our balanced capital allocation strategy, reflecting the durability of our business model and positive long-term outlook," said Eric Vaillancourt, CEO.

16:31 EST Antero Resources: Net production to average 3.2-3.3 Bcfe/d in 2022

16:28 EST Boston Beer Chairman says 'confident' in FY22 volume growth of 4%-10% - "Our broad portfolio of successful brands, all of which grew depletions in the fourth quarter, helped Boston Beer solidify our leadership position in several categories," said Chairman and Founder Jim Koch. "In fact, Twisted Tea was the fastest-growing of the top 25 brands in the fourth quarter with 31% growth in measured channels, and with 8% growth in measured channels in the fourth quarter, Samuel Adams was the fastest-growing national craft brand. Our 27% depletions CAGR over the past three years demonstrates that we have a broad, advantaged portfolio of brands, and our innovation pipeline continues to ensure we can meet consumer taste trends as they evolve. The first major launch of our 2022 innovation pipeline, Truly Margarita, is generating tremendous results and already has a 5.3% market share of hard seltzer with limited distribution thus far. With three innovations for 2022 announced today - Truly Vodka, the limited summer offering Truly Poolside, and an exciting new collaboration between Dogfish Head and Patagonia to launch an environmentally conscious pilsner - we remain confident that we can grow full-year volume between 4% and 10% in 2022, as our inventory levels continue to recover."

16:26 EST Nvidia cites regulatory challenges for termination of Arm acquisition - The company said, "On February 8, 2022, NVIDIA and SoftBank Group Corp. (SoftBank) announced the termination of the Share Purchase Agreement whereby NVIDIA would have acquired Arm Limited from SoftBank. The parties agreed to terminate because of significant regulatory challenges preventing the consummation of the transaction. NVIDIA intends to record in operating expenses a $1.36 billion charge (the Arm Write-off) in the first quarter of fiscal 2023 reflecting the write-off of the prepayment provided at signing in September 2020."

16:25 EST Fisker sees FY22 CapEx $280M-$290M - Sees FY22 total opex $435M-$500M.

16:25 EST Churchill Downs names Nate Simon CTO - Churchill Down announced that Nate Simon has been named Senior Vice President and Chief Technology Officer of the Company. In this role, he will be responsible for providing strategic technology leadership and services. Simon replaces Ben Murr who was promoted to President of TwinSpires and Online Gaming in January.

16:23 EST Boston Properties says construction resumes on Platform 16 Project in San Jose - Boston Properties announced that construction has resumed on the first phase of the Platform 16 development project in San Jose. The first phase of the development will include the construction of an approximately 390,000 square foot Class A creative office building, which is expected to be ready for client fit-out in late 2024, and a below-grade parking garage. BXP owns a 55% interest in, and provides development, property management, and leasing services to the joint venture that owns Platform 16. Canada Pension Plan Investment Board owns the remaining 45% interest. Platform 16 is a fully entitled, 1.1 million square foot Class A, creative office campus located in downtown San Jose on an approximately 5.6 acre site. The development is adjacent to Google's planned eight million square foot Downtown West and Diridon Station, a major Bay Area transportation hub. Designed by Kohn Pederson Fox, the urban campus will include three buildings, 16 private outdoor terraces with unobstructed views of the city, two pedestrian plazas for social gatherings and corporate events, and onsite amenities, including a large fitness and wellness center and a cafe. The development will have immediate access to the adjacent Guadalupe River Park, as well as various retail and restaurant amenities. "We are thrilled to have recommenced construction at Platform 16," said Bob Pester, Executive Vice President, San Francisco Region, BXP. "The larger South Bay community, and San Jose specifically, continues to see demand for high-quality, creative workspaces outpace supply. Platform 16 combines an ideal location with the design and amenities that today's most innovative firms are seeking to recruit, retain, and motivate their workforces."

16:20 EST Cheesecake Factory: Q1-to-date comp sales up 24.3% y/y

16:15 EST Pioneer Natural sees Q1 oil production 348-363 MBOPD - First quarter 2022 oil production is forecasted to average between 348 to 363 MBOPD and total production is expected to average between 620 to 645 MBOEPD. Production costs are expected to average $9.25 per BOE to $10.75 per BOE. DD&A expense is expected to average $10.50 per BOE to $12.00 per BOE. Total exploration and abandonment expense is forecasted to be $10 million to $20 million. G&A expense is expected to be $68 million to $78 million. Interest expense is expected to be $36 million to $41 million. Other expense is forecasted to be $15 million to $30 million. Accretion of discount on asset retirement obligations is expected to be $2 million to $5 million. The cash flow impact related to purchases and sales of oil and gas, including firm transportation, is expected to be a loss of $25 million to $55 million, based on forward oil price estimates for the quarter. The Company's effective income tax rate is expected to be between 22% to 27%, with cash taxes expected to be $10 million to $20 million, principally representing estimated state taxes.

16:11 EST Altice USA announces acceleration in fiber deployment strategy - Altice USA announces an acceleration of its fiber deployment strategy over the next four years across its Optimum and Suddenlink footprint, expecting to reach 6.5 million passings by the end of 2025. "This new fiber expansion in Suddenlink coupled with the continued fiber build in Optimum will position the Company to pass more than two thirds of its entire footprint with 100% fiber broadband over the next four years, including approximately 2.5 million fiber passings at Suddenlink and 4 million fiber passings at Optimum. Altice USA has been building a fiber broadband network in its Optimum territory in the New York tri-state area with 1.2 million fiber passings available for sales as of December 31, 2021. For Suddenlink, construction is expected to begin this year in areas of Texas. Additional states in the Suddenlink footprint that will benefit from this fiber expansion plan include areas of Arizona, California, Louisiana, Missouri, North Carolina, New Mexico, Oklahoma, and West Virginia," the company said. "Altice USA is proud to announce plans to invest further in our fiber deployment strategy by accelerating the build of a 100% fiber broadband network capable of delivering multi-gig speeds across our Optimum and Suddenlink footprint. Fiber is the future and given the progress we have made at Optimum with our fiber expansion, we're excited to build on that success and break ground later this year at Suddenlink to bring our advanced network to more customers and communities," added CEO Dexter Goei.

16:10 EST Amylyx says FDA panel to review NDA for AMX0035 - Amylyx Pharmaceuticals, Inc. announced that a virtual meeting of the U.S. Food and Drug Administration's Peripheral and Central Nervous System Drugs Advisory Committee to review the New Drug Application for AMX0035 has been scheduled for March 30, 2022. AMX0035 is an investigational therapy for the treatment of amyotrophic lateral sclerosis. As previously reported, the U.S. FDA has granted Priority Review and assigned a Prescription Drug User Fee Act date for AMX0035 of June 29, 2022. "There are few treatments approved for ALS, a devastating disease that impacts a person's ability to move, speak, eat and breathe," said Lahar Mehta, M.D., Head of Global Clinical Development of Amylyx. "We look forward to a robust scientific discussion with the members of the advisory committee panel regarding the clinical data submitted to support our New Drug Application for AMX0035."

16:09 EST DoorDash sees FY22 marketplace GOV $48B-$50B, adjusted EBITDA $0-$500M

16:09 EST Cisco raises dividend 3%, announces additional $15B share buyback program

16:08 EST Biocept names Riccitelli interim CEO, Morales interim CFO - Biocept announced the appointments of Samuel D. Riccitelli as Interim President and Chief Executive Officer, succeeding Michael W. Nall, and Antonino Morales as Interim Chief Financial Officer, succeeding Timothy C. Kennedy. Biocept also named M. Faye Wilson as Lead Independent Director of the company's Board of Directors. Mr. Riccitelli remains Chair of the Board. "I am grateful and excited to see Sam and Antonino stepping into their interim roles at a time when Biocept is fulfilling such an important mission for our current COVID-19 testing clients and I am even more excited about what their leadership will mean to malignant tumor patients as we pursue the clinical validation of the CNSide assay in identifying metastatic cancer originating from all solid tumors," said M. Faye Wilson, Lead Independent Director of Biocept.

16:05 EST Century Communities raises quarterly dividend by 33% to 20c per share - The dividend is payable on March 16, 2022 to stockholders of record as of the close of business on March 2, 2022.

15:49 EST Education Department approves $415M in borrower defense claims - Nearly 16,000 borrowers will receive $415M in borrower defense to repayment discharges following the approval of four new findings and the continued review of claims, the Education Department announced. "This includes approximately 1,800 former DeVry University students who will receive approximately $71.7 million in full borrower defense discharges after the U.S. Department of Education determined that the institution made widespread substantial misrepresentations about its job placement rates... During this period of misrepresentation, DeVry was a publicly traded company owned by DeVry Education Group Inc., which was later renamed Adtalem Global Education. Senior leaders at DeVry during this time included Daniel Hamburger, who served as President and CEO from 2002 through 2016 and David Pauldine, who served as the executive vice president and/or president of DeVry University from 2005 through 2014. Adtalem sold DeVry in 2018," the Department stated. Reference Link

15:27 EST New Jersey reports January gaming revenue up 10.3% to $381.7M - Based upon filings with the Division of Gaming Enforcement, total casino win for the nine casino hotel properties was $183.6M for January, reflecting growth of 14.8% compared to $160M for January 2021. For the month of January, internet gaming win reported by casinos and their partners was $137.8M, reflecting growth of 32.8% compared to $103.8M for the prior period. Sports wagering gross revenue reported by casinos, racetracks, and their partners was $60.2M for the month, reflecting a 26.9% decline when compared to $82.4M for the prior period. Total gaming revenue reported by casinos, racetracks, and their partners was $381.7M for January, reflecting a 10.3% increase from $346.2M reported in January 2021. Publicly traded companies in the space include Boyd Gaming (BYD), Caesars (CZR), Churchill Downs (CHDN), DraftKings (DKNG), Flutter Entertainment (PDYPY), Gan Limited (GAN), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN), William Hill (WIMHY) and Wynn Resorts (WYNN). Reference Link

14:19 EST Zendesk says to 'carefully review and evaluate' Jana director nominees - Zendesk issued the following statement confirming receipt of JANA Partners' notice of its intention to nominate four directors to the Zendesk board of directors at the company's 2022 annual meeting of stockholders, which has not yet been scheduled: "We have always and will continue to welcome input from all shareholders, and in keeping with our long-held practice of maintaining a high caliber board with exceptionally qualified directors, our Nominating and Corporate Governance Committee will carefully review and evaluate these nominees. The Zendesk Board has been built by balancing the benefits of tenure and experience with the need for fresh ideas and perspectives and with a consistent view toward diversity of thought, experience and perspectives. As the Board considers its nominees in connection with the 2022 Annual Meeting, it will remain committed to these principles of independence, diversity, shareholder perspective and relevant expertise."

13:39 EST North American rail traffic up 4.3% in week ended February 12 - The Association of American Railroads, AAR, reported U.S. rail traffic for the week ending February 12. For this week, total U.S. weekly rail traffic was 504,482 carloads and intermodal units, up 5% compared with the same week last year. Total carloads for the week ending February 12 were 236,457 carloads, up 11.9% compared with the same week in 2021, while U.S. weekly intermodal volume was 268,025 containers and trailers, down 0.4% compared to 2021. North American rail volume for the week ending February 12, on 12 reporting U.S., Canadian and Mexican railroads totaled 329,598 carloads, up 9.3% compared with the same week last year, and 350,974 intermodal units, down 0.1% compared with last year. Total combined weekly rail traffic in North America was 680,572 carloads and intermodal units, up 4.3%. North American rail volume for the first six weeks of 2022 was 3,879,720 carloads and intermodal units, down 7.8% compared with 2021. Publicly traded companies in the space include CSX (CSX), Canadian National (CNI), Canadian Pacific (CP), Kansas City Southern (KSU), Norfolk Southern (NSC), Union Pacific (UNP), Greenbrier (GBX), Trinity Industries (TRN), FreightCar America (RAIL) and Wabtec (WAB). Reference Link

12:40 EST Sherwin-Williams raises quarterly dividend to 60c from 55c - Sherwin-Williams announced a regular quarterly dividend of 60c per common share, an increase of 9% over the 55c paid in the same quarter in 2021. This is payable on March 11, to shareholders of record on February 28.

12:31 EST Microsoft pulls AltspaceVR's social hubs amid safety, moderation push - Microsoft said in a blog post that it is removing all social hubs hosted in AltspaceVR, including the Campfire, News and Entertainment Commons. "As platforms like AltspaceVR evolve, it is important that we look at existing experiences and evaluate whether they're adequately serving the needs of customers today and in the future," said Altspace's Alex Kipman. "This includes helping people better connect with those who have shared common interests while also ensuring the spaces they access are safe from inappropriate behavior and harassment." Microsoft added that the Existing Safety Bubble feature will now be turned on by default and that new attendees joining Events will be automatically muted. "In addition to these immediate changes, in the coming weeks we will improve content rating for Events and increase moderation on the platform," Kipman added. "We will also require all users to log-in to AltspaceVR using a Microsoft Account (MSA or AAD). Just as we do for Xbox, Windows, and other Microsoft services, we will integrate MSA accounts with Microsoft Family Safety, allowing parents to approve or limit access to AltspaceVR for 13+ family members who download AltspaceVR from the Microsoft Store. We will communicate the exact timing and how parents can implement these changes in the months ahead."Reference Link

12:19 EST Trade Desk sees 'good chance' of positive impact from Google announcement - Trade Desk (TTD) CEO Jeffrey Green says he is "incredibly encouraged" by the way Google's announcement is rolling out and that he thinks there is a "good chance" of it having a positive impact on the business. Green added that "this move by Google is not a surprise." Google will stop cross-app tracking on Android phones, following a similar move by Apple (AAPL), according to The Wall Street Journal. Comments taken from Trade Desk's Q4 earnings conference call.

12:04 EST UK to offer Pfizer COVID-19 vaccines for five- to 11-year-olds - United Kingdom Health and Social Care Secretary Sajid Javid issued the following statement on the vaccination of five- to 11-year-olds following updated advice from the Joint Committee on Vaccination and Immunisation: "I have accepted the advice from the independent Joint Committee on Vaccination and Immunisation to make a non-urgent offer of COVID-19 vaccines to all children aged five to 11 in England. The NHS is already offering vaccines to at-risk children and those who live with immunosuppressed people in this age group. The JCVI advice follows a thorough review by our independent medicines regulator, the MHRA, which approved Pfizer's paediatric vaccine as safe and effective for children aged five to 11. Children without underlying health conditions are at low risk of serious illness from COVID-19 and the priority remains for the NHS to offer vaccines and boosters to adults and vulnerable young people, as well as to catch-up with other childhood immunisation programmes. The NHS will prepare to extend this non-urgent offer to all children during April so parents can, if they want, take up the offer to increase protection against potential future waves of COVID-19 as we learn to live with this virus." Reference Link

12:01 EST Squarespace falls -19.7% - Squarespace is down -19.7%, or -$6.77 to $27.54.

12:00 EST Flex LNG rises 11.2% - Flex LNG is up 11.2%, or $2.25 to $22.38.

12:00 EST Generac rises 13.1% - Generac is up 13.1%, or $36.12 to $312.82.

11:47 EST Poxel announces PXL065 granted FDA fast track designation for AMN - POXEL SA announced that the U.S. FDA has granted Fast Track Designation to PXL065 for the treatment of patients with adrenomyeloneuropathy, or AMN, the most common form of X-linked adrenoleukodystrophy. PXL065 is a novel, proprietary deuterium-stabilized R-stereoisomer of pioglitazone that is preparing to enter into a Phase 2a clinical Proof-of-Conceptbiomarker study midyear. Poxel CEO, Thomas Kuhn, commented: "By awarding Fast Track Designation to PXL065, the FDA recognizes the drug's potential to address a significant unmet medical need for patients with ALD, where no approved therapies currently exist. This is a very powerful acknowledgement and good news for patients waiting to be treated. Fast Track Designation confers multiple benefits that are of great value and have the potential to substantially accelerate the approval timeline for PXL065 in ALD. We look forward to working closely with the FDA as we prepare to embark on our Phase 2a clinical study for PXL065 now planned to begin midyear, followed by results in early 2023." The Phase 2a clinical POC biomarker study for PXL065 in X-linked ALD is anticipated to begin midyear, followed by results in early 2023.

11:16 EST Exro Technologies files defamation lawsuit against ePropelled Inc. - Exro Technologies announced that it has filed a defamation lawsuit against ePropelled Inc. on February 15, 2022, in Middlesex County Superior Court in the Commonwealth of Massachusetts. The company said, "This litigation concerns the bad faith tactics of ePropelled in publishing a demonstrably untrue and defamatory statement about Exro in a press release issued on January 24, 2022.: "Exro stands with conviction against the false claims made in the defamatory press release issued by ePropelled last month," said Exro CEO Sue Ozdemir. "It is our responsibility to uphold the reputation of Exro and its technology while protecting our shareholders. We are pursuing this lawsuit to hold ePropelled accountable for its tortious conduct."

11:03 EST Disney introduces Storyliving by Disney, to develop residential communities - Heather Hunter, Public Relations Director for Disney Signature Experiences, said in a blog post that "As more fans look for new ways to make Disney a bigger part of their lives, today we are announcing plans to introduce Storyliving by Disney, vibrant new neighborhoods that are infused with our special brand of magic. Each community will feature distinctively designed spaces, unique amenities and Disney's brand of world-renowned service. These master-planned, new home communities are intended to inspire residents to foster new friendships, pursue their interests and write the next exciting chapter in their lives -all while enjoying the attention to detail and special touches that are Disney hallmarks. And where will the first one be? None other than a place that has known the footsteps of Walt Disney himself! Cotino, a Storyliving by Disney community, will be built in the heart of the Coachella Valley in Rancho Mirage, Calif." Reference Link

10:56 EST Optibase confirms receipt of unsolicited tender offer - Optibase confirmed that it has received notice that The Capri Family Foundation, a foundation organized under the laws of the Republic of Panama and ShlomoWyler have commended an unsolicited tender offer to purchase 941,942 outstanding ordinary shares, nominal value NIS 0.65 per share, of Optibase, not already owned by the Bidder group, at $11.60 per Share, net to the seller in cash, less any applicable withholding taxes, and without interest. The tender offer follows a prior similar offer, commenced by the Bidder on December 1, 2021, to purchase Company Shares at $11.20. The prior offer expired by its terms on December 30, 2021. The minimum condition was not met in the prior offer and all tendered shares were returned.

10:28 EST Lixiang Education Holding Company Ltd (ADS) trading resumes

10:23 EST Lixiang Education Holding Company Ltd (ADS) trading halted, volatility trading pause

10:10 EST Intergrated Media Technology Ltd trading halted, volatility trading pause

10:00 EST Toast falls -18.3% - Toast is down -18.3%, or -$5.16 to $22.96.

10:00 EST Roblox falls -22.2% - Roblox is down -22.2%, or -$16.25 to $57.05.

10:00 EST Crescent Energy rises 9.2% - Crescent Energy is up 9.2%, or $1.25 to $14.84.

09:58 EST Western Global Airlines purchases two Boeing 777 Freighters - Boeing and Western Global Airlines announced a firm order for two 777 Freighters, the first new-production freighters for the all-Boeing cargo operator based in Estero, Fla. The order was finalized in January 2022 and is currently listed as unidentified in Boeing's order backlog. The agreement also includes an additional purchase option.

09:47 EST Modiv falls -18.9% - Modiv is down -18.9%, or -$5.85 to $25.15.

09:47 EST Roblox falls -20.8% - Roblox is down -20.8%, or -$15.23 to $58.07.

09:47 EST Preferred Apartment rises 8.0% - Preferred Apartment is up 8.0%, or $1.87 to $25.15.

09:42 EST Aerovate Therapeutics Inc trading halted, volatility trading pause

09:41 EST Liontown announces binding term sheet for supply of lithium to Tesla - Australian-based battery materials company Liontown Resources announces that it has entered into a "legally binding sales and purchase term sheet" with electric vehicle manufacturer Tesla for the supply of spodumene concentrate. The agreement is for the supply of up to 150,000 dry metric tonnes, or "DMT," per annum of spodumene concentrate to be produced at Liontown's Kathleen Valley Lithium Project in Western Australia and is expected to commence in 2024, representing approximately one-third of the project's start-up SC6.0 production capacity of about 500ktpa, Liontown announced. Reference Link

09:38 EST Masimo trading resumes

09:34 EST QualTek Services Inc trading halted, volatility trading pause

09:33 EST Vroom announces new Extended Mile hub in Statesville, North Carolina - Vroom, Inc. announced its new Extended Mile hub in Statesville, North Carolina. Similar to Vroom's Last Mile hubs but with broader reach, the new Extended Mile hub provides a more customized driveway experience for 2.6 million people in more than 600 ZIP codes across North Carolina.

09:29 EST Adial Pharmaceuticals announces closing of $10M financing - Adial Pharmaceuticals announced the closing of its previously announced registered direct offering, whereby a single accredited institutional investor purchased approximately $10 million of the Company's common stock and pre-funded warrants, as well as warrants to purchase common stock in a concurrent private placement. The combined effective purchase price for one share of common stock and a warrant to purchase 0.95 shares of common stock was $2.40. Under the terms of the securities purchase agreement, Adial sold 2,322,250 shares of common stock and pre-funded warrants to purchase up to1,865,000 shares of common stock. Adial also issued warrants to purchase up to an aggregate of 3,977,888 shares of common stock. The warrants are exercisable six months from the date of issuance, expire five and a half years from the date of issuance, and have an exercise price of $2.52 per share of common stock. The net proceeds of the offering strengthen Adial's balance sheet as it moves toward completion of the Company's Phase 3 ONWARD trial and are intended primarily for working capital and other general corporate purposes. This capital is expected to support potential regulatory and commercialization activities related to AD04, pursuing strategic initiatives, and advancing preclinical and clinical activities related to the Company's Purnovate adenosine platform, among other purposes.

09:26 EST SuperCom Chairman purchased 917,000 SPCB shares in the open market - SuperCom announced that its Chairman of the Board, Arie Trabelsi, has notified the company that he has recently purchased an additional 405,000 SPCB shares in the open market, on top of the 512,000 SPCB shares he purchased and announced on December 30 2021. This leads to a total of 917,000 SPCB shares purchased recently as part of his purchase program to purchase up to 3M SPCB shares in the open market.

09:23 EST American Battery Metals secures additional 1,800 acres of lithium-bearing claims - American Battery Technology Company announced that it is in the process of staking 90 additional surface sedimentary lithium-bearing claims covering approximately 1,800 acres that will expand their Tonopah Flats Lithium Exploration Project in Big Smokey Valley, Nev. to a total of approximately 10,340 acres. As previously announced, ABTC has delivered its initial Tonopah Flats lithium samples for analysis for high throughput screening analysis. The company has decided to substantially expand its claims in the area, and will also continue with additional exploratory drilling while thorough analyses of subsequent samples are underway. The company will continue conducting geological mapping, sampling, geochemical analysis, and proprietary extraction trials to characterize these high potential resources and to quantify the performance of its internally developed lithium extraction and manufacturing operations. As the company further accelerates the commercialization of its internally developed process train for the manufacturing of battery grade lithium hydroxide product from this unique type of lithium-bearing surface sedimentary resource at its claims near Tonopah, Nev., it has initiated the process of exiting its positions in the Railroad Valley area and its associated brine claims. The company has sold 224 of their 644 unpatented placer claims in this Western Nevada Basin located in Nye County, Nevada to Ameriwest Lithium Inc., a North American lithium exploration and development company. As part of the company's battery metals resource development exploration efforts, ABTC is performing bench scale characterization and extraction trials to confirm the technical and economic feasibility of extracting elemental lithium from these acquired resources in order to produce battery grade lithium hydroxide, and other high value lithium products, for sale to the battery metals market. ABTC's sale of WNB claims, in combination with the expansion of its lithium-bearing surface sedimentary claims in Big Smokey Valley, follows an evolution in strategy and an emphasis on the sampling and characterization of lithium-bearing claystone sedimentary resources in the Tonopah Flats Lithium Exploration Project.

09:20 EST NextPlay Technologies' NextBank selected by Alphabit's ABCC cryptocurrency - NextPlay Technologies announced that NextBank International, the international banking unit of its fintech division, has signed a Memorandum of Understanding, MOU, with Alphabit Consulting to provide deposit accounts and payment cards for members of its ABCC cryptocurrency exchange. The NextBank accounts will maintain ABCC users' fiat cash balances, permitting them to trade between fiat currency and cryptocurrency on ABCC exchange. Account holders will also be able to apply for payment cards that would allow them to make payments secured by their cryptocurrency balances. "ABCC is an exceptionally well-managed and fast-growing crypto exchange, making them the perfect partner to launch payment cards with," stated Todd Bonner, chairman of NextPlay Technologies and head of the company's fintech division. "We expect the regulatory licenses will further support trader and investor confidence, and further accelerate the growth of the ABCC platform. This new partnership also advances our efforts to expand the capabilities of our fintech division through the offering of products and services that appeal to companies within the digital asset industry."

09:19 EST Diana Shipping delivers Kamsarmax dry bulk vessel, time charter contract - Diana Shipping announced that, through a separate wholly-owned subsidiary, it has taken delivery of the m/v Leonidas P. C., a 2011 built Kamsarmax dry bulk vessel of 82,165 dwt that the Company entered into an agreement to purchase in July 2021. As previously announced, the m/v Leonidas P. C. is time chartered to Cargill International S.A., Geneva, at a gross charter rate of $24,500 per day, minus a 4.75% commission paid to third parties, for a period until minimum March 1, 2023 up to maximum April 30, 2023. The charter is expected to commence on February 18, 2022. The Company also announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Solebay Shipping Cape Company Limited, Hong Kong, for one of its Capesize dry bulk vessels, the m/v Seattle. The gross charter rate is $26,500 per day, minus a 5% commission paid to third parties, for a period until minimum October 1, 2023 up to maximum December 15, 2023. The charter is expected to commence on February 23, 2022. The employments of "Leonidas P. C." and "Seattle" are anticipated to generate approximately $24.41M of gross revenue for the minimum scheduled period of the time charters. Including the newly delivered m/v Leonidas P. C., Diana Shipping Inc.'s fleet currently consists of 34 dry bulk vessels. The Company also expects to take delivery of one new-building Capesize dry bulk vessel by the end of the first quarter of 2022.

09:18 EST TriNet to become WeWork's U.S. professional employer organization partner - TriNet (TNET) announced an exclusive partnership with WeWork (WE) to become the company's professional employer organization partner in the United States. Through the partnership, WeWork's SMB members will be able to purchase full-service HR solutions from TriNet. Additionally, TriNet employees, as well as its 23,000 SMB clients-which span more than 600,000 people-will be provided with the option to purchase WeWork All Access memberships at a discounted rate.

09:16 EST Momentive urges shareholders to vote for Zendesk transaction - Momentive Global (MNTV) sent a letter urging stockholders to vote "FOR" all proposals relating to the proposed transaction with Zendesk, Inc. (ZEN) at the upcoming Special Meeting of Stockholders on February 25, 2022. The letter read, in part, " Momentive's Special Meeting of Stockholders on February 25th is rapidly approaching. You have the opportunity to vote for the proposed combination with Zendesk, which the Momentive Board of Directors unanimously believes is the best path forward for Momentive and will create significant and compelling value for Momentive stockholders. But don't just take the Momentive Board's word for it - as announced on February 11, leading independent proxy advisory firm Institutional Shareholder Services has also recommended that Momentive stockholders vote "FOR" the transaction with Zendesk. ISS Supports the Momentive Board's Recommendation to Vote "FOR" the Value-Enhancing Transaction with Zendesk Today: There are numerous reasons why stockholders should support Momentive's transaction with Zendesk. Among the most compelling are: Momentive stockholders will own approximately 22% of a faster-growing, more profitable company with greater revenue scale: Customer intelligence is more important than ever, and together, Zendesk and Momentive are uniquely suited to deliver a highly differentiated platform that no other software vendor currently provides. The combined company is expected to serve a $165 billion addressable market by 2025 and generate revenue at a 27% compound annual growth rate from 2021 to 2025.1 Additionally, the combined company is expected to generate $4.6 billion in revenue and achieve 14-16% non-GAAP operating margin by 2025.1 Put simply, in becoming part of a larger combined organization, Momentive expects to generate higher revenue growth at a significantly larger revenue scale with greater profitability, delivering many compelling financial benefits that it would otherwise not be able to achieve on its own. The transaction delivers compelling value to Momentive stockholders: The transaction structure provides upside participation for Momentive stockholders. The exchange ratio of 0.225 represents a greater than 30% premium to Momentive's one-month, three-month, and one-year unaffected historical exchange ratios.2 Furthermore, as supported by discounted cash flow valuation analyses by Momentive's independent financial advisors, the intrinsic valuation of the transaction represents more than $35 per share, providing Momentive stockholders with an attractive 22% premium compared to the intrinsic valuation of its standalone plan. The Momentive Board undertook a comprehensive review of strategic alternatives through a process designed to enhance stockholder value: In arriving at the transaction with Zendesk, the Momentive Board created a strategic committee of three independent Board members to oversee the process and provide recommendations to the full Board. The process led to engagement with 18 potential acquirors, three written proposals, and multiple price increases from multiple parties. Ultimately, the Board was unanimous in support of a transaction with Zendesk - the highest price with the highest intrinsic value for Momentive stockholders. Vote on the WHITE Proxy Card to Participate in the Upside Potential of the Combined Company: Join ISS in supporting Momentive's transformational proposed transaction with Zendesk. Please take a moment to vote "FOR" the proposals set forth on the enclosed WHITE proxy card today - by internet, telephone toll-free or by signing, dating and returning the enclosed proxy card in the postage-paid envelope provided."

09:13 EST Old National, First Midwest complete merger of equals - Old National Bancorp (ONB) and First Midwest Bancorp, (FMBI) jointly announced they have completed their all-stock merger of equals, announced on June 1, 2021. "This combination makes us one of the Midwest's largest commercial banks and positions us well for continued expansion, investment, and innovation in talent, capabilities and services," said Mike Scudder, Executive Chairman of the combined company. "We look forward to building upon the strong legacy of exceptional relationship banking and community engagement that both banks have developed over several decades to create even more opportunities to help our clients achieve financial success." The combined organization will operate under the Old National Bancorp and Old National Bank names, with dual headquarters in Evansville and Chicago. Board of Directors: The combined company's Board of Directors consists of 16 members with eight directors from Old National and eight directors from First Midwest: Mike Scudder, Executive Chairman; Becky Skillman, Lead Independent Director; Barbara Boigegrain; Tom Brown; Kathryn Hayley; Pete Henseler; Dan Hermann; Ryan Kitchell; Austin Ramirez; Ellen Rudnick; Jim Ryan; Tom Salmon; Michael Small; Derrick Stewart; Steve Van Ardsell; and Kathy White. Shares of First Midwest ceased trading after the closing of the NASDAQ stock market on February 15, 2022. The combined company's common shares will trade on NASDAQ under ticker symbol "ONB."

09:12 EST Evans Bancorp increases semi-annual cash dividend to 62c per share - Evans Bancorp announced that at its meeting yesterday, the Board of Directors declared a cash dividend of 62c per share on its outstanding common stock. This semi-annual dividend represents a 2c increase from the previous semi-annual dividend paid in October 2021.

09:10 EST CPI Aerostructures awarded contract worth up to $20M from Raytheon Intelligence - CPI Aerostructures (CVU) announced that it has been awarded a long-term, indefinite delivery indefinite quantity contract from Raytheon Intelligence & Space, a Raytheon Technologies (RTX) business, worth up to a potential $20M to provide rack assemblies for RI&S' B-52 AESA radar. CPI Aero received an initial $4N order for prototype and test article production of the rack assembly that the AESA radar will be mounted in and then installed within the nose of the B-52. Work will commence immediately with first delivery anticipated in late 2022. Douglas McCrosson, President & CEO of CPI Aerostructures, commented, "This new program award reflects our demonstrated reliability and quality, and expands our footprint with one of our top customers. Upgrades for weapon systems that lie at the core of our country's national security mission is an increasingly important part of our defense business and we are confident we will add value to the B-52 Radar Modernization Program team."

09:08 EST AMD announces availability of Amazon EC2 C6a instances - AMD announced the expansion of Amazon Web Services AMD EPYC processor-based offerings with the general availability of compute optimized Amazon EC2 C6a instances. According to AWS, the C6a instances offer up to 15% better compute price performance over previous generation C5a instances for a variety of compute focused workloads. The C6a instances support compute-intensive workloads such as batch processing, distributed analytics, ad serving, highly scalable multiplayer gaming, and video encoding. This is the second AWS EC2 instance type powered by 3rd Gen AMD EPYC processors, following the release of the M6a instances. These instances continue the collaboration between AWS and AMD providing AWS EC2 customers access to the performance and price performance capabilities of the latest generation of AMD EPYC processors.

09:08 EST Progenity shares oral presentation on treatment of gastrointestinal disorders - Progenity shared an oral presentation that was delivered by Dr. Bram Verstockt during the 34th edition of the Belgian Week of Gastroenterology on February 9, 2022. During the oral presentation titled "Tofacitinib tissue exposure correlates with endoscopic outcome," lead author Dr. Verstockt presented patient data demonstrating a significant relationship between mucosal exposure and endoscopic improvement in patients with moderate to severe ulcerative colitis who were treated with tofacitinib. "These data support the hypothesis that targeted delivery of tofacitinib to the site of disease has the potential to improve patient outcomes. This will be further explored in clinical trials with PGN-600 to determine whether Progenity's targeted approach can increase mucosal exposure and decrease systemic exposure," said Adi Mohanty, Chief Executive Officer of Progenity. "With this technology, we anticipate successful delivery of higher therapeutic doses directly to the mucosa while avoiding current issues with toxicity due to systemic uptake. We thank the clinical teams responsible for this independent study, in particular those at IBD Leuven and Amsterdam UMC, for their excellent work toward our shared goal of better therapeutic efficacy for IBD patients."

09:07 EST First Quantum Minerals board approves final dividend of C$0.005 per share - First Quantum Minerals announced that its Board of Directors has approved a final dividend of $0.005 Canadian dollar per share in respect of the financial year ending December 31, 2021. This, together with the interim dividend of CDN$0.005, makes a total of CDN$0.01 for the 2021 financial year. The dividend will be paid on May 6, 2022 to shareholders of record on April 14, 2022. The Company has established a Dividend Reinvestment and Share Purchase Plan for its Canadian resident shareholders. The Plan enables Eligible Shareholders to reinvest the cash dividends paid on all or a portion of their Common Shares into additional Common Shares, which will be issued at 97% of the Average Market Price and provides the opportunity to make optional cash purchases of additional Common Shares on a semi-annual basis, on dividend payment dates.

09:06 EST Hancock Whitney announces pact with Cetera Financial for investment services - Hancock Whitney announced a strategic relationship with Cetera Financial Group to provide Hancock Whitney clients with enhanced broker-dealer and investment advisory services. Hancock Whitney Investment Services, a registered broker-dealer, member FINRA/SIPC, and an SEC Registered Investment Advisor, will transition its client investment services business to Cetera, operating under the name "Hancock Whitney Financial Consultants," pending regulatory approval. HWIS, a wholly owned subsidiary of Hancock Whitney Corporation will remain in place as a limited broker-dealer for corporate and municipal underwriting. Cetera is one of the largest independent broker-dealers in the country. "Providing our clients a best-in-class, advice based experience is our priority and core to our organization's century-old commitment to service. The opportunity to work with Cetera aligns very well with our strategic vision and direction. This relationship will support us in meeting our clients' investment needs through superior broker-dealer and investment advisory services, enhanced products and digital user experiences, and more opportunities to help clients grow and protect their assets," said Hancock Whitney Chief Wealth Management Officer Miles Milton.

09:04 EST T2 Biosystems announces commercial expansion in Norway, Finland, Turkiye - T2 Biosystems announced the execution of territory exclusive distribution agreements in Norway, Finland, and Turkiye. Under the terms of the agreements, T2 Biosystems will sell T2Dx Instruments, along with T2Bacteria, T2Candida and T2Resistance Panels through these distributors. The execution of these exclusive distribution agreements further expands T2 Biosystems' commercialization. "We are committed to expanding our commercialization worldwide and these new distribution agreements provide access to important markets in Norway, Finland, and Turkiye," said John Sperzel, Chairman and CEO of T2 Biosystems. "We believe these three countries represent significant growth potential for our culture-independent rapid diagnostics and look forward to building lasting relationships with our distributors as we work to improve the quality of care for those patients at risk of sepsis."

09:02 EST Nvidia enters partnership with Jaguar Land Rover - Jaguar Land Rover has formed a multi-year strategic partnership with NVIDIA to jointly develop and deliver next-generation automated driving systems plus AI-enabled services and experiences for its customers. Starting in 2025, all new Jaguar and Land Rover vehicles will be built on the NVIDIA DRIVE software-defined platform - delivering a wide spectrum of active safety, automated driving and parking systems as well as driver assistance systems. Inside the vehicle, the system will deliver AI features, including driver and occupant monitoring, as well as advanced visualisation of the vehicle's environment. Jaguar Land Rover will also leverage in-house developed data centre solutions with NVIDIA DGX for training AI models and DRIVE Sim software built on NVIDIA Omniverse for real-time physically accurate simulation. Jensen Huang, NVIDIA founder and Chief Executive Officer, said: "Next-generation cars will transform automotive into one of the largest and most advanced technology industries. Fleets of software-defined, programmable cars will offer new functionalities and services for the life of the vehicles. We are thrilled to partner with Jaguar Land Rover to reimagine the future of transportation and create the most advanced cars."

09:02 EST Taboola awarded IAB UK Gold Standard 2.0 certification - Taboola announced it has been awarded the Gold Standard 2.0 Certification by the IAB UK, the United Kingdom's industry body for digital advertising. By achieving this certification, the IAB has verified Taboola, through a thorough vetting process, as a technology provider that upholds high standards in brand safety, user experience and more.

09:01 EST TD Synnex, Claroty announce partnership - Claroty announced its partnership with TD SYNNEX. The agreement enables Claroty's channel partners to purchase The Claroty Platform, the first industrial cybersecurity solution to be made available in TD SYNNEX's portfolio, directly through TD SYNNEX. Additionally, Medigate by Claroty, healthcare's leading clinical device data security and integration platform, is now available in TD SYNNEX's portfolio as well.

08:43 EST Organon acquires rights for contraceptive products Marvelon, Mercilon in China - Organon (OGN) announced that it has acquired the rights from Bayer (BAYRY) to Marvelon and Mercilon , combined oral hormonal daily contraceptive pills, in the People's Republic of China, including Hong Kong and Macau, and has entered into an agreement to acquire the rights to these products in Vietnam. Marvelon and Mercilon are already owned, manufactured, and marketed by Organon as prescription oral contraceptives in 20 other markets. This acquisition gives Organon full global ownership of these brands by reacquiring the rights to them in these markets. The agreement to acquire the rights in Vietnam is expected to close in the first half of 2022 and is subject to customary closing conditions, including regulatory approval. "This is an important opportunity for Organon as we look to grow our contraception portfolio and further bolster our offerings to women in all parts of the world through strategic business development," said Susanne Fiedler, Chief Commercial Officer at Organon. "With Marvelon and Mercilon in the People's Republic of China, including Hong Kong and Macau, and potentially Vietnam, we will have an opportunity to reach more women who are looking for contraceptive options in these markets and help to empower them with choice in an area of health that is important to them." Marvelon is currently available over the counter in the People's Republic of China and both Marvelon and Mercilon are available over the counter in Hong Kong and Macau. Marvelon and Mercilon are currently available by prescription in Vietnam. Both contraceptives were acquired by Bayer AG in these markets from Merck & Co., Inc. in 2014 as part of the sale of Merck & Co.'s consumer care business. Marvelon and Mercilon are not available in the United States.

08:36 EST Tandem Diabetes announces FDA clearance for t:slim X2 insulin pump - Tandem Diabetes announced FDA clearance of bolus insulin dosing on the t:slim X2 insulin pump using the t:connect mobile app. This represents the first-ever FDA-cleared smartphone application capable of initiating insulin delivery on both iOS and Android operating systems. The updated t:connect mobile app is designed to offer t:slim X2 insulin pump users the ability to program and cancel bolus insulin requests through the convenience of their compatible smartphone.

08:35 EST Skye Bioscience reports data from SBI-100 in GLP toxicology study - Skye Bioscience announced that it has completed a good laboratory practice, GLP, nonclinical toxicology study of its SBI-100 ophthalmic nanoemulsion in support of the Company's planned Phase 1 first-in-human clinical trial in Australia. The purpose of this study was to evaluate the ocular toxicity and toxicokinetics of SBI-100 ophthalmic nanoemulsion when administered to rabbits either two or three times daily at multiple doses by topical ocular administration for fourteen consecutive days. The reversibility of potential test article-related effects was also assessed following a drug-free recovery period. No histological changes were observed in the eye and no adverse findings in remaining organs resulting from SBI-100 administration. Based on these results, a no-observed-adverse-effect level was observed, allowing for the determination of a starting dose for the upcoming Phase 1 clinical trial. "We believe there is potential for SBI-100 to be a disruptive and potentially transformative treatment option for patients suffering from glaucoma. We have worked diligently to complete the preclinical steps required for our submission to the Australian Therapeutic Goods Administration, and these positive GLP toxicology results represent the final nonclinical dataset needed to complete our submission," said Tu Diep, Chief Development Officer. "Upon receiving the required approvals from the Australian regulatory agencies, we plan to initiate our Phase 1 clinical trial of SBI-100 and dose our first patient in the second quarter of 2022."

08:34 EST Viant announces strategic alliance with Commerce Signals - Viant Technology announced a new partnership with Commerce Signals, a Verisk Financial business and leader in payment-based insights and ad effectiveness solutions. This strategic alliance is a key driver for Viant, as the company continues to bolster its holistic measurement solutions, delivering clients true return-on-ad-spend, ROAS. "Measurement has been and will continue to be a key focus for Viant, and Commerce Signals' expertise in consumer credit and debit card transactional data is an important component in elevating our existing solutions," said Tom Wolfe, SVP, Business Development, Viant. "Actionable metrics including incremental return on ad spend and lift in buyer penetration provide key insights that ultimately drive customer success." Commerce Signals enables marketers access to the largest source of consumer payments behavior data to improve marketing outcomes. In campaign measurement, Commerce Signals matches ad impressions to card spending and then shares back the aggregate spending for groups of consumers, across all addressable platforms, such as CTV and OTT. Ultimately, if impressions can be tracked to an individual or household, Commerce Signals can measure their incremental sales impact. "We are delighted to be working with Viant to combine our companies' capabilities to help agencies and brand marketers maximize their ROAS," said Andy Mantis, President, Commerce Signals. "By connecting advertising impressions to omnichannel card spend data, increasing sales impact will be an attainable goal for clients."

08:33 EST Capital Square 1031 acquires state-of-the-art Amazon distribution facility - Capital Square 1031 announced the acquisition of a 2,690,000-square-foot distribution facility on a long-term absolute net lease to Amazon.com. The facility was acquired on behalf of CS1031 Zero Coupon Fulfillment Center, DST.

08:33 EST BioRestorative Therapies announces notice of allowance on patent for BRTX-100 - BioRestorative Therapies announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company's BRTX-100 core clinical program. Claims granted under the key patent cover a method of preparing BRTX-100, a stem cell population derived from bone marrow, grown under hypoxic conditions, and used to treat avascular zones, such as the intervertebral disc. The method of preparing stem cells under low oxygen conditions is designed to optimize the therapeutic potential of the cells once implanted in the low oxygen environment of the damaged disc.

08:32 EST eFfector Therapeutics appoints Kristen Harrington-Smith to boardImmunoGen - eFFECTOR Therapeutics (EFTR) announced the appointment of Kristen Harrington-Smith, Senior Vice President & Chief Commercial Officer at ImmunoGen (IMGN), to the company's board of directors. Concurrent with Ms. Harrington-Smith's appointment, Jonathan Root, M.D., has resigned from the company's board of directors.

08:29 EST Paramount raising global streaming subscriber goal to more than 100M by end 2024 - Last night, Paramount said Paramount+ has "exceeded the company's goals since its launch, and ahead of schedule, as the key driver of ViacomCBS' overall streaming growth." The company, which is rebranding from ViacomCBS, said it delivered more than 56M total global streaming subscribers and 84% revenue growth in the direct-to-consumer segment in 2021. "As a result of its streaming momentum and incremental investments, the company is raising its global streaming subscriber goal from 65-75 million global streaming subscribers to more than 100 million subscribers by year-end 2024. The company is also raising its 2024 DTC revenue goal from $6 billion to $9 billion," Paramount said. "In just one year, Paramount+ has outperformed all expectations. Our powerful content, marketing and distribution engines drove explosive growth as further proof of our ability to establish a sustainable, large scale streaming business with a differentiated global playbook," added CFO Naveen Chopra. In addition, Paramount said Paramount+ subscribers will soon be able to enjoy Showtime in a new integrated offering. "Starting this summer in the U.S., Paramount+ subscribers will be able to upgrade their subscription to a bundle that includes the SHOWTIME service through two plans," the company noted. Showtime will also remain available as a standalone premium OTT subscription service and through various third-party streaming platforms, the company said.

08:25 EST ViacomCBS to change name to Paramount, Class B ticker to 'PARA' - ViacomCBS last night announced that the global media company will become Paramount Global, referred to as "Paramount,", effective February 16, stating that the move brings together its "leading portfolio of premium entertainment properties under a new parent company name." President and CEO Bob Bakish said: "Paramount's iconic peak represents a rich history for our company as pioneers in the Golden Age of Hollywood. Today, as we embrace the Paramount name, we are pioneers of an exciting new future." The company's shares will trade on the Nasdaq stock exchange as "PARAA" for Class A common, "PARA" for Class B common and "PARAP" for Preferred Stock, beginning with trading on February 17 at 9:30 a.m. ET. In addition to the name change, the company detailed plans to accelerate momentum behind Paramount+, unveiling new content, enhanced product offerings and continued international expansion at its investor event. The company announced that starting with 2024 film releases, Paramount+ will become the streaming home for all new Paramount Pictures movies in the U.S. following their theatrical runs. "We see a huge global opportunity in streaming, a much larger potential market than can be captured by linear TV and film alone. We're excited about our ability to not just compete, but thrive, creating significant value for both consumers and shareholders. How? Because we're broader in four key areas: our diverse content, streaming model, mix of platforms and global reach. As we look forward, the size of the opportunity we see is matched only by our ambition to seize it," added Bakish. With Paramount+ and SkyShowtime, the company will have streaming services available in more than 60 markets across the UK, Latin America, Canada, Australia, South Korea, the Caribbean and all major markets in Europe by the end of this year. In 2023, the company will look to Asia, Africa and the Middle East, building on Paramount+'s strong momentum to grow its presence in every region of the world, it said.

08:22 EST Blockchain Intelligence Group, U.S. federal agency extend C$588K contract - BIGG Digital Assets, owner of Blockchain Intelligence Group is pleased to announce a contract extension for year three with a United States federal government agency bringing total contract value to C$588,462. Blockchain Intelligence Group supplies forensic technology for cryptocurrencies to support investigations and training. The agency name is withheld due to its critical national security mission. Blockchain Intelligence Group also signed contracts in the last two months with two US banks with contract values of CAD $96.5K.

08:20 EST ProPhase Labs declares special cash dividend of 30c per share - ProPhase Labs announced that its Board of Directors has declared a special cash dividend in the amount of $0.30 per share on its common stock, payable on March 10, 2022 to stockholders of record as of March 1, 2022.

08:20 EST Stellantis to outline long-term strategic plan on March 1 - Stellantis N.V announced it will outline its long-term strategic plan on Tuesday, March 1, 2022 at 2 p.m. CET / 8 a.m. EST. Carlos Tavares, CEO, will share Stellantis' long-term strategic plan to further define how the Company intends to lead the way the world moves.

08:17 EST District of Columba chooses UnitedHealthcare for its Dual Choice program - The District of Columbia has selected UnitedHealthcare to administer its District Dual Choice program. The contract term is February 1 , through December 31 which the district may extend up to four additional one-year periods. UnitedHealthcare will initially serve approximately 12,300 District Dual Choice program enrollees. UnitedHealthcare will continue to work closely with the Department of Health Care Finance, which administers the District of Columbia District Dual Choice program as part of its Medicaid program, to improve the overall health and well-being of enrollees through a value-based, whole-person, and integrated care model. "We are committed to partnering with the Department of Health Care Finance to continue building a strong District Dual Choice program that provides individualized care to meet the health and wellness needs of enrollees," said Erin Henderson Moore, executive director, UnitedHealthcare Community Plan of Washington, D.C. "We are honored to serve the health care needs of our enrollees in the district through innovative programs and community investments that reduce health disparities."

08:17 EST Global Internet of People launches CEM program - Global Internet of People announced that Global Mentor Board Education Technology, GMB Education, a newly established subsidiary of the Company's variable interest entity, launched a carbon emission management training program, CEM Program, in February, 2022. The CEM Program is aimed at helping trainees to prepare for the qualification exams and obtain professional certificates issued by China Energy Conservation Association, a non-profit organization that promotes energy efficient technology and products. Haiping Hu, Chairman of the Board and Chief Executive Officer of SDH, commented: "By launching this training program, we are expanding our business into the Chinese vocational education market, following the trend of China's education reform that encourages vocational education. With our market resources and brand influence, we are committed to building our vocational training platform and launching more programs in the future."

08:16 EST Rhythm announces interim data from long-term extension study of setmelanotide - Rhythm Pharmaceuticals announced positive interim data from its long-term extension study evaluating setmelanotide in patients with Bardet-Biedl Syndrome, BBS. Rhythm will review these data, as well as provide an update on ongoing preparations in support of a potential U.S. commercial launch of IMCIVREE for the treatment of obesity and hyperphagia in patients with BBS, during a virtual event for investors and analysts beginning today. Of the patients enrolled in Rhythm's long-term extension trial, 19 individuals with BBS have reached 24 months on therapy. As of a data cutoff date of October 29, 2021: The mean percent reduction in body mass index from pivotal trial baseline was -14.3%; The mean percent reduction in body weight from pivotal trial baseline among patients 18 years of age or older was -14.9%; The mean reduction in BMI Z score from pivotal trial baseline among patients younger than 18 was -0.72. Consistent with prior clinical observations, setmelanotide was generally well-tolerated in the long-term extension study and no new safety signals were observed. Rhythm plans to present detailed results from this study at a major medical meeting later this year. Also at the event, Rhythm management will provide an update on ongoing preparations in support of a U.S. commercial launch of setmelanotide for the treatment of obesity and hyperphagia in individuals with BBS, pending approval by the U.S. Food and Drug Administration.

08:13 EST Hyperfine announces Queen's University receives Hyperfine Portable MRI - Hyperfine announces that Queen's University and Kingston Health Sciences Centre are deploying a Swoop system as part of their health services benefitting six communities located in the James Bay and Hudson Bay Area. Until now, patients needing routine or emergent care required transportation by medical charter flight hundreds of miles away to either Timmins or Kingston, ON. Queen's University intends to utilize Swoop as part of a study to build evidence regarding the utility and affordability of a portable point of care, POC, MRI in a remote setting. "Until recently, the technology for portable point of care imaging has not existed-resulting in inequitable access to healthcare and putting people at great risk simply due to their geographical limitations," said Khan Siddiqui, M.D., chief medical officer and chief strategy officer of Hyperfine. "Swoop was designed to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care."

08:13 EST Meten Edtechx provides updates on cryptocurrency business - Meten Holding (METX) provided an update on the company's cryptocurrency business. To date, the company has put 867 mining machines into operation, consisting of 147 mining machines purchased in small batches and 720 mining machines purchased from AGM Group (AGMH). The remaining 615 mining machines purchased from AGMH are expected to be deployed and put into operation by the end of this month. The company currently has a total of 1482 units of Bitcoin mining machines with a computing power of approximately 150PH/s. In addition, the company has recently purchased 600 XP mining machines from Bitmain Technologies with an aggregate computing power of approximately 100PH/s. These mining machines are expected to be delivered in the second half of this year. The company intends to continue to develop its cryptocurrency business through purchasing more mining machines.

08:12 EST Splash Beverage secures distribution for SALT Tequila through Gulf Distributing - Splash Beverage announced that it has secured distribution through Gulf Distributing of Alabama for the Company's SALT Naturally Flavored Tequila for the state of Alabama, and participating military bases. Gulf Distributing of Alabama is a division of Gulf Distributing Holdings which manages and operates 7 individual beverage distributors that encompass central and southern Alabama and markets in Mississippi. GDH represents over 100 suppliers and services over 10,000 retail accounts in its assigned territories. Splash Beverage CEO Robert Nistico states, "We have a long-standing relationship with Gulf Distribution, and we are extremely excited to be working with their team. Our brand, SALT Naturally Flavored Tequila, joins their blue-chip portfolio of beverages, including Coors, Heineken, Corona, Red Bull, Essentia Water, 7-Up and Snapple, and TapouT Performance Beverage in Alabama."

08:11 EST AGCO launches Massey Ferguson S Series Tractors - AGCO Corporation ushered in a new era of straightforward dependability and farmer-focused technology with the North American launch of the Massey Ferguson S Series Tractors. Composed of four series - the MF 5S, MF 6S, MF 7S and MF 8S Series - this versatile tractor lineup combines cutting-edge features with Massey Ferguson's proven reliability for a cost-effective, farmer-driven equipment solution. Massey Ferguson will debut the full MF S Series lineup, together for the first time, at booth 7823 during the National Farm Machinery Show in Louisville, Kentucky, February 16-19.

08:10 EST Katapult selects Poly & Bark to join retail network - Katapult has selected Poly & Bark to join its retailer network to give shoppers more options when looking to obtain quality furniture and to help non-prime customers gain access to durable goods, including furniture. Katapult's lease-to-own solution will provide Poly & Bark the ability to offer transparent, customer-centric lease-purchase options and access more customers who previously may not have had a way to purchase the goods they need.

08:09 EST Corporacion America Airport reports January traffic up 78.6% - Corporacion America Airport reported a 78.6% increase in passenger traffic in January, and a 37% decline when compared to the same period of 2019. Reports January cargo volume up 22.8% vs. 2021. Reports toal aircraft movements up 25.1% vs. 2021.

08:09 EST E-Home Household enters metaverse with business transformation initiatives - E-Home Household Service Holdings announced that the Company will enter the metaverse space with digitalized business transformation initiatives. The Company plans to launch future online marketing campaign via the creation of metaverse brand ambassadors and to provide 24/7 customer service as well as training for household services personnel in the virtual world containing immersive experiences in on-demand training video, networking with customers and intelligent household services. E-Home will set up an artificial intelligence technology unit and form strategic collaborations with various AI technology partners to develop the Metaverse platform that bridges the digital and physical world to meet customers' demand in this new digitalized era.

08:08 EST Datadobi awarded NCPA contract with Climb Channel Solutions - Datadobi announced NCPA members can now purchase Datadobi's software suite through the cooperative via its distribution partner Climb Channel Solutions. The partnership continues Datadobi's momentum in the U.S. federal sector, and comes after the company was awarded a position on Climb Channel Solutions' GSA IT 70 Contract and a listing on the federal government's list of SEWP vendors.

08:06 EST CytomX Therapeutics announces employment inducement grants - CytomX Therapeutics announced that on February 16, 2022, the Company granted nine new employees options to purchase a total of 189,400 shares of the Company's common stock at an exercise price per share equal to $4.08, which was the closing trading price on February 15, 2022, the date of the grant. The stock options were granted pursuant to the Company's 2019 Employment Inducement Incentive Plan, which was approved by the Company's board of directors in August 2020 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.

08:06 EST Better Therapeutics announces first patient enrolled in BT-001 study - Better Therapeutics announced the first patient has been enrolled in a real-world evidence study to evaluate the long-term effectiveness and healthcare utilization changes associated with the use of BT-001 for the treatment of type 2 diabetes. The open-label, randomized, controlled study is actively recruiting patients with type 2 diabetes from the University of Colorado Health System.

08:05 EST CELLINK, CollPlant enter collaboration agreement - CELLINK, a BICO Group company, and CollPlant Biotechnologies announced they have signed a collaboration agreement. Under this collaboration, CELLINK's high-throughput, multi-material extrusion bioprinter will be explored for the development of large-scale production of CollPlant's 3D bioprinted regenerative breast implants, addressing a current market size of $2.8B, with 2.2M procedures performed annually worldwide.

08:05 EST Horizon Therapeutics announces results from Uplizna analysis - Horizon Therapeutics announced results from a new analysis showing treatment with Uplizna effectively reduced the severity of attacks in people with NMOSD. These data are being presented at the 48th Annual Meeting of the North American Neuro-Ophthalmology Society. Uplizna is the first and only B-cell-depleting agent approved by the FDA for the treatment of NMOSD in adults who are anti-aquaporin-4 antibody positive. Of the 18 total attacks that occurred in the Uplizna treatment group during the RCP, 12 were minor and six were major, compared to 12 minor attacks and 10 major attacks among the 22 attacks occurring in the placebo group. Levels of the sGFAP biomarker were significantly higher during major attacks versus minor attacks overall and trended higher for optic neuritis, or ON, specific attacks. Concentration levels of the biomarker increased significantly from baseline at the time of attacks in those receiving placebo but not in those treated with Uplizna. SNfL levels were higher for major versus minor attacks overall, though the levels did not correlate with the severity of ON attacks. In participants that had attacks during the RCP, rates of this marker were higher among placebo versus Uplizna-treated participants at Week 26.

08:03 EST Byrna Technologies to commence $30M share repurchase program - Byrna Technologies announced that its Board of Directors has authorized the commencement of purchases of its common stock pursuant to the $30M Repurchase Program announced in early December. To date, no stock has been repurchased because the company has been in a standard blackout period in advance of its earnings release late last week. Bryan Ganz, President and CEO of Byrna, commented, "The Board's approval of the Repurchase Program launch reflects the confidence that the Board and management have in Byrna's operating fundamentals, business opportunities, and growth prospects."

07:49 EST Flora Growth signs agreement with Artos to sell cannabis flower to Israel - Flora Growth announced that the company has signed an agreement with Artos to sell approximately 3,600 kg of dried high-THC cannabis flower to Israel from its Cosechemos cultivation facility. Through this agreement, Flora Growth seeks to establish a partnership with the Artos team to expand their offering of cannabis products for the Israeli market to also include oils and, when regulations permit, finished THC and CBD consumer products. The export of the high-THC product is pending the dried-flower checklist from the Colombian government from the 2021 update to the cannabis law.

07:47 EST Fairfax Financial acquires additional Fairfax India shares - airfax Financial Holdings (FRFHF) announces that it has acquired, through its subsidiaries, an aggregate of 5,416,000 subordinate voting shares of Fairfax India Holdings Corporation (FFXDF), representing 4.93% of the issued and outstanding Subordinate Voting Shares of Fairfax India, from two existing shareholders at a price of $12.00 per Subordinate Voting Share for an aggregate purchase price of approximately $64.9M. Prior to the Share Purchase, Fairfax beneficially owned, and/or exercised control or direction over, 23,030,285 Subordinate Voting Shares, representing 20.97% of Fairfax India's issued and outstanding Subordinate Voting Shares, and 30,000,000 multiple voting shares of Fairfax India, representing 100% of the issued and outstanding Multiple Voting Shares. Fairfax's aggregate ownership, control and/or direction of the Subordinate Voting Shares and Multiple Voting Shares before giving effect to the Share Purchase represented a 37.92% equity interest and a 94.61% voting interest in Fairfax India. After giving effect to the Share Purchase, Fairfax now beneficially owns, and/or exercises control or direction over, 28,446,285 Subordinate Voting Shares, representing 25.90% of Fairfax India's issued and outstanding Subordinate Voting Shares, and 30,000,000 Multiple Voting Shares, representing 100% of the issued and outstanding Multiple Voting Shares. Fairfax's aggregate ownership, control and direction of the Subordinate Voting Shares and Multiple Voting Shares following completion of the Share Purchase represents a 41.80% equity interest and a 94.94% voting interest in Fairfax India.

07:45 EST Plymouth Industrial REIT boosts dividend 4.8% to 22c per share - Plymouth Industrial REIT announced that its board of directors has declared a 4.8% increase in the Company's regular quarterly cash dividend to 22c per share of common stock, effective for the first quarter of 2022. The dividend, which equates to an annualized rate of 88c per common share, is payable on April 29 to stockholders of record as of the close of business on March 31. Jeff Witherell, Chairman and Chief Executive Officer of Plymouth, noted, "The continued growth in our portfolio, as evidenced by the previously announced strong fourth quarter leasing, acquisition and capital markets activity, enabled us to increase our quarterly dividend for the second straight year."

07:42 EST Vulcan Materials CFO Suzanne Wood to retire, Mary Andrews Carlisle to succeed - Vulcan Materials announced that Suzanne Wood has decided to retire as Senior Vice President and CFO effective September 1. Wood will then remain with the company in a consulting capacity until the end of the year. The Board of Directors has appointed Mary Andrews Carlisle, Vice President - Finance, as Wood's successor, effective September 1. Carlisle has served Vulcan in roles of increasing responsibility in multiple divisions as well as in corporate finance groups and business development since 2006. Additionally, Vulcan announced today that Darren Hicks, who is currently Vulcan's Vice President - Human Resources, has been appointed to the newly-created role of Senior Vice President and Chief Human Resources Officer, effective March 1.

07:40 EST Cytokinetics, the AHA Bay Area announce three-year collaboration - Cytokinetics announced a three-year collaboration to accelerate education and awareness of heart disease. Within the collaboration, Cytokinetics will provide funding and support for several initiatives led by AHA Bay Area. In 2022, Cytokinetics will sponsor the Research Roundtable, a life-sciences industry fundraising event. Cytokinetics will also support several Bay Area Heart Walks by establishing an enhanced VIP area for patients and caregivers. Additionally, Cytokinetics will support the development of three new patient videos in the AHA series. "Partnering with the AHA Bay Area helps us fulfill our responsibility of supporting those in our community, and there's no better time to announce this collaboration than during Heart Month," said Robert Blum, President and Chief Executive Officer of Cytokinetics. "Heart disease is the leading cause of death in the U.S., and for many diseases such as heart failure, the prevalence is only increasing. As we remain dedicated to our mission to address unmet needs in diseases like heart failure and hypertrophic cardiomyopathy, it remains a top priority to elevate attention of heart disease, and we look forward to continuing to work together with the AHA Bay Area to advance their goals and initiatives."

07:40 EST Vertex Indirect Tax Chain Flow Accelerator certified by SAP - Vertex announced that its Vertex Indirect Tax Chain Flow Accelerator is certified by SAP for integration with SAP S/4HANA. The integration enables customers to achieve fully automated and consistent value added tax treatment with their SAP S/4HANA software.

07:39 EST Monarch obtains $1M from Metalla following Baufor agreement amendment - MONARCH MINING CORPORATION announced the signing of an amendment to the agreement regarding the 1% net smelter return royalty on gold production from the Beaufor Mine owned by Metalla Royalty & Streaming. In consideration for a $1M cash payment to Monarch, the clause stipulating that the Royalty will be exempt until 100,000 ounces of gold have been produced following Monarch's acquisition of Beaufor will be removed, making the agreement effective immediately for both parties. Concurrently, the Corporation also closed its transaction announced on February 7, 2022 with Triple Flag Precious Metals.

07:37 EST Icanic Brands announces issuance of cease trade order - Icanic Brands Company is announcing that it has been issued a Cease Trade Order by the British Columbia Securities Commission under National Policy 11-207. On November 30, 2021, the Company announced that, for reasons disclosed below, there would be a delay in the filing of its financial statements and accompanying management's discussion and analysis for the fiscal year ended July 31, 2021 beyond the period prescribed under applicable Canadian securities laws. In addition, the delay in the annual statements has resulted in the interim financial statements and accompanying management discussion and analysis for the three-month period ended October 31, 2021, being delayed beyond the period prescribed. The Company previously announced that the British Columbia Securities Commission had granted a further extension of the Management Cease Trade Order through February 11, 2022. As previously announced, the Company has been delayed in completing its audited financial statements as a result of Covid-19 related delays in obtaining information with respect to subsidiaries acquired during the current and prior year, as well as a change in auditors from the previous fiscal year. The previous acquisitions and auditor change has required certain expert reports and an increase in the overall scope of the audit, both of which have caused the delay in the Annual Filings. The Company is actively and expeditiously working with its auditors to file the Annual Filings, at which point the Company will seek to have the CTO revoked and trading reinstated on the CSE. The Company also confirms, as of the date of this news release, that there is no other material information concerning the affairs of the Company that has not been generally disclosed. The Company is also pleased to report that it has been diligently working towards closing the acquisition of LEEF Holdings, Inc., as previously announced on January 25, 2022. Closing of the Acquisition is subject to shareholder and regulatory approvals and several closing conditions, including the filing of Icanic's Annual Filings and the removal of the CTO.

07:36 EST Wingstop reaffirms 3- to 5-year domestic SSS growth in mid-single digits

07:35 EST Mandalay Resources provides 2021 mineral reserves for Costerfield, Bjorkdal - Mandalay Resources Corporation is pleased to announce updated Mineral Resources and Reserves estimates for its Costerfield gold-antimony mine in Victoria, Australia and its Bjorkdal gold mine in Skellefteundefined, Sweden as at December 31, 2021. Highlights: Costerfield: Proven and Probable Mineral Reserves for contained gold increased by 24%, net of depletion for 2021 production; and Extended mine life by two years to 2027, net of depletion for 2021 production. Bjorkdal: Maintains long mine life until 2030; Improved geological understanding allowing for upgrade to higher confidence Measured Resources and Proven Reserves; and Increase to Measured and Indicated gold Resources of 59,000 oz net of yearly depletion. Dominic Duffy, President and CEO of Mandalay, commented: "Mandalay's exploration efforts in 2021 yielded significant success. We made major additions of Mineral Reserves at Costerfield through the successful discovery of the Shepherd zone below the Youle deposit, and discovered significantly higher gold grades to the east at depth at Bjorkdal. As 2021 year-end, Mandalay's total Proven and Probable Mineral Reserves totaled 854,000 ounces of gold and 19,600 tonnes of antimony, compared to 799,000 ounces of gold and 21,800 tonnes of antimony at 2020 year-end. These Mineral Reserves were added at an exploration cost of $30.79 per gold equivalent ounce; further evidence of the cost effectiveness and sustainability of our exploration programs. To date, five continuous high-grade veins have been discovered within Shepherd and it is expected to be an area of substantial Mineral Resources and Reserves growth over the coming years. During the 10 months from discovery to data cut-off in 2021, Shepherd has already added 296,000 tonnes of ore at a grade of 12.4 g/t gold and 1.0% antimony into Mineral Reserves. This significant contribution in a short timespan highlights the richness of the Costerfield mineral system. Currently, the Shepherd veins are open and will be the focus of ongoing exploration efforts at Costerfield. At Bjorkdal, due to its current long mine life of approximately nine years, the exploration focus was not on Mineral Reserve addition, but on identifying areas that could potentially add higher-grade mine feed. This program was extremely successful with the discovery of the high-grade zones to the east at depth of the Main and Central zones. Most of the significant results for this area were recovered after the data cut-off point for this Mineral Resources and Reserves update, hence the success of this program and the significant potential in upgrading the overall grades will be better reflected in the following years and will be a continued exploration focus at Bjorkdal during 2022. Looking forward into 2022, alongside the continuation of growth projects around Shepherd and the Eastern Extension projects, Mandalay is advancing several highly prospective areas at both properties. At Bjorkdal, exploration continues north of the Aurora orebody as well as the commencement of surface drilling on regional Bjorkdal style and multi-element targets. At Costerfield, the potential of further Youle and Shepherd style targets will continue to be explored in parallel with renewed efforts on satellite deposits within 2 km of the mining activities."

07:33 EST InflaRx reports progress in ongoing Phase II trial with vilobelimab - InflaRx announced the start of the second dosing cohort of the vilobelimab and PD-1 checkpoint inhibitor, pembrolizumab, combination arm of the Phase II clinical trial in cutaneous squamous cell carcinoma, cSCC. The Phase II trial is ongoing at sites in Europe, the U.S. and elsewhere. The study is investigating two independent arms: vilobelimab alone and vilobelimab in combination with pembrolizumab. The main objectives of the trial are to assess the safety and antitumor activity of vilobelimab monotherapy and to determine the maximum tolerated or recommended dose, safety and antitumor activity in the combination arm. In the combination Arm B, three patients have been treated for at least 36 days in the first dosing cohort of the study. The data from the first 36 days of treatment have been reviewed by the Steering Committee and no safety concerns were raised. The Steering Committee recommended to continue the study as planned. The interim analysis in Arm B required to move to the second stage of the Phase II trial is expected after ten patients have been treated and are evaluable for response assessment at the recommended Phase II dose level. These data are expected to be available in the first quarter of 2023. In parallel, enrollment continues in the monotherapy Arm A. The interim analysis in Arm A required to proceed to the second stage is expected to be available after ten patients are evaluable for response assessment. These data are expected to be available in the third quarter of 2022.

07:26 EST Parsons awarded contract to continue managing Faro Mine remediation - Parsons Corporation announced that the company has been awarded a contract to provide main construction management and care & maintenance services at Faro Mine in Faro, Yukon, Canada. Once the world's largest open pit lead-zinc mine, the Faro Mine Remediation Project is one of the largest and most complex abandoned mine clean-up projects in Canada. Parsons' contract could span over 20 years and exceed $2B. Parsons has supported the Government of Canada, Yukon Government, First Nations, and the Town of Faro in remediating the site since 2016. Under the contract, Parsons will provide site management services including overall occupational health and safety; environmental and geotechnical management; project management; construction management; and procurement services for the work that will be completed to implement the remediation plan. Parsons will also continue to be responsible for the care and maintenance of the site. A critical objective for the contract is development and successful implementation of a socio-economic strategy to bring economic benefits to the local First Nations communities of the Kaska Dena.

07:20 EST Equillium acquires Bioniz Therapeutics, announced departure of CMO Dolca Thomas - Equillium announced that it has acquired Bioniz Therapeutics, a privately held clinical-stage biotechnology company. Bioniz developed its novel structured-domain peptides, including BNZ-1 and BNZ-2, entirely in-house from its proprietary product discovery platform. The Bioniz lead product candidates are multi-specific inhibitors of disease-driving, clinically validated cytokine targets aimed at addressing unmet needs across a range of immuno-inflammatory indications. Following the acquisition, Dolca Thomas, chief medical officer and executive vice president of research and development at Equillium, will be leaving the company. With the acquisition of Bioniz, Equillium obtained exclusive worldwide rights to all current and future Bioniz products. The transaction consideration is comprised of an all-stock upfront payment of 5,699,492 unregistered shares of common stock of Equillium issuable to Bioniz stockholders, which represents approximately 19.3% of Equillium's outstanding capital stock. Approximately 97% of the issued Equillium stock is subject to a standard six-month lock-up provision and thereafter will be released ratably each month over the following 6 months. Equillium is also obligated to pay Bioniz stockholders up to $57.5M in potential development milestone payments across three Bioniz clinical candidates beginning upon first U.S. marketing approval, and up to $250M in sales milestone payments based upon BNZ-1 achieving calendar year global net sales. Other than the aforementioned milestones, Equillium does not have any third-party obligations with respect to milestones or royalties related to the Bioniz products or platform. Equillium has sole discretion over the timing and extent of advancing clinical development of the Bioniz products. Bioniz was estimated to have modestly positive net working capital at closing.

07:18 EST Enanta doses 1st patient in study of EDP-235 protease inhibitor for Covid - Enanta Pharmaceuticals announced that it has dosed the first subject in its Phase 1 clinical trial of EDP-235, a coronavirus 3CL protease inhibitor specifically designed as a once-daily, oral treatment for COVID-19. "SARS-CoV-2 continues to infect millions of individuals worldwide and new variants are still emerging, highlighting the limitations of current therapies and vaccines for COVID-19. There remains an urgent need for highly potent, oral treatments designed specifically to treat and prevent COVID-19, and we believe that the profile of EDP-235 positions it to potentially be a best-in-class antiviral therapeutic," said Jay R. Luly Ph.D., President and Chief Executive Officer of Enanta Pharmaceuticals. "We are excited to reach this milestone and begin our EDP-235 clinical program, with the first subject being dosed in this Phase 1 study. Looking to the rest of the year, we plan to report data from this study in the second quarter of 2022 and, assuming positive findings, we expect to advance EDP-235 to the next stage of clinical development in the second half of 2022." ..Preclinical data show that EDP-235 potently blocks the replication of SARS-CoV-2 in multiple cellular models, including primary human airway epithelial cells where an EC90 of 33 nanomolar was observed, positioning EDP-235 among the most potent direct-acting antivirals currently in development for SARS-CoV-2 infection. Preclinical studies demonstrate that EDP-235 has good oral bioavailability without ritonavir boosting and favorable distribution into lung cells as well as other key target tissues, with expected once-daily human dosing. Importantly, in addition to SARS-CoV-2, EDP-235 has potent antiviral activity against other human coronaviruses, enabling the potential for a pan-coronavirus treatment, including possibly coronaviruses that may infect human populations in the future.

07:16 EST Altair Engineering acquires Cassini, terms not disclosed - Altair acquired Cassini, a next-generation cloud native technology for Industry 4.0. With the acquisition, Altair deepens its expertise and strengthens its ability to offer digital thread solutions via the Altair One cloud platform. Cassini is based in Hyderabad, India.

07:14 EST Milestone Pharmaceuticals names David Bharucha as Chief Medical Officer - Milestone Pharmaceuticals announced the appointment of David Bharucha, M.D., Ph.D., as Chief Medical Officer, effective February 15. Dr. Bharucha is a cardiac electrophysiologist who brings to Milestone over thirty years of global drug development and clinical experience across a range of therapeutic areas, with a focus on cardiovascular medicine. He will replace Francis Plat, M.D., who will transition to Chief Scientific Officer of the company and, following the completion of the Phase 3 RAPID trial in the second half of 2022, will serve in an advisory capacity.

07:12 EST Webster Financial to acquire Bend Financial, terms not disclosed - Webster Financial announced that it has signed a definitive agreement to acquire Bend Financial, a cloud-based platform solution provider for health savings accounts. Bend's client-facing experience utilizes cloud native technology and user-centered design to offer a simplified and modern approach to HSA management and engagement. Terms of the transaction were not disclosed. The transaction is expected to be completed promptly in the first quarter.

07:09 EST Kraft Heinz sees FY22 organic net sales up low-single-digit percentage - The company said, "The Company expects to deliver strong financial performance in 2022. The Company currently expects a low-single-digit percentage increase in 2022 Organic Net Sales(4) versus the prior year period, reflecting continued stronger consumption versus pre-pandemic levels. Adjusted EBITDA(4) is expected to be in the range of $5.8 billion to $6.0 billion, reflecting a 53rd week in 2022, the impact of divestitures versus the prior year, strong Organic Net Sales as well as the Company's ongoing efforts to manage inflationary pressures as it continues to invest in long-term growth."

07:08 EST Vinco Ventures completes acquisition of AdRizer - Vinco Ventures announced it has completed the previously announced acquisition of AdRizer for consideration consisting of $38M in cash paid at closing and up to 10M shares of common stock of Vinco issuable on January 1, 2024. ZVV Media Partners, a joint venture of Vinco and Zash Global Media and Entertainment, ZASH, and ZASH assigned their rights to acquire AdRizer to Vinco in connection with the transaction. As a result of the acquisition, AdRizer is now a wholly-owned subsidiary of Vinco. Ken Bond, the founder and CEO of AdRizer, will continue as CEO of AdRizer under a three-year employment agreement with AdRizer. "With the AdRizer acquisition complete, we are now focused on deploying AdRizer's technology platform to monetize the content creation and streaming capabilities of the Lomotif short form video app through digital advertising," said Lisa King, CEO of Vinco.

07:05 EST Shopify sees y/y revenue growth lowest in 1Q22, highest in Q4 - The company said: "We do not expect the COVID-triggered acceleration of ecommerce in the first half of 2021 from lockdowns and government stimulus to repeat in the first half of 2022. Second, our new terms with apps and theme developers cause two differences from last year's first quarter: the elimination of Shopify's rev share on partners' first million dollars of revenue annually reset on January 1st, and the shift from gross to net revenue recognition for the sale of themes as a result of revised contract terms with our theme partners. Since these terms didn't come into play until the second half of last year, these will be a headwind to Subscriptions Solutions revenue in the first half of 2022, particularly in the first quarter. And third, we expect certain commercial initiatives and sales and marketing investments will gain momentum over the course of 2022." Sees FY22 Subscriptions Solutions revenue growth to be driven by more merchants around the world joining the platform than in 2021. Sees FY22 Merchant Solutions revenue growth to be more than twice the rate of subscription solutions revenue growth year-over-year.

07:01 EST Crescent Energy acquires oil assets in Uinta Basin - Crescent Energy has entered into a definitive purchase agreement with Verdun Oil Company II to acquire Uinta Basin assets previously owned by EP Energy for $815M, subject to customary purchase price adjustments. The all-cash transaction, expected to close in the first half of 2022, will be funded through the company's revolving credit facility and cash on hand. The acquisition is expected to generate ~55% accretion to annualized cash flow per share and ~30% accretion to annualized free cash flow per share, increase annualized Adjusted EBITDAX by $400M-$465M at $75/Bbl pricing, ~85% of which is from existing production and current drilled but uncompleted wells; a multi-year inventory of high value, oil-weighted development opportunities; planning to operate two rigs on the assets in 2022 post-closing, increases the company's percent operated to ~70% based on 2022 expected production. The transaction will be funded with borrowings under Crescent's revolving credit facility and cash on hand. The company's current liquidity pro forma for the elected commitment amount increase is $1.1B. Crescent is acquiring over 400 producing vertical and horizontal wells. The transaction will provide Crescent with more than 145,000 contiguous net acres greater than 85% held-by-production, primarily located in Duchesne and Uintah counties, Utah. The capital associated with this program is expected to be $225M-$275M and Crescent's revised 2022 capital budget is expected to be $600M-$700M.

07:00 EST Bristol-Myers: Phase 3 VALOR-HCM trial met primary endpoint - Bristol Myers Squibb announced that VALOR-HCM, the Phase 3 randomized, double-blind, placebo-controlled study evaluating mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy, met its primary endpoint at Week 16. The safety of mavacamten was consistent with previous studies. "We are encouraged by the findings from this important study, which add to the growing body of clinical evidence that supports the promise of mavacamten for patients living with obstructive HCM," said Roland Chen, M.D., Senior Vice President, Cardiovascular Development at Bristol Myers Squibb. "We look forward to sharing the results from VALOR-HCM at the American College of Cardiology 71st Annual Scientific Session & Expo taking place in April." The company plans to share these data with regulatory authorities. Bristol Myers Squibb thanks the patients and investigators participating in the VALOR-HCM clinical trial.

06:57 EST Sonic Automotive raises quarterly dividend 108% to 25c per share - Sonic's Board of Directors approved a quarterly cash dividend of 25c per share payable on April 14 to all stockholders of record on March 15, raising the quarterly dividend by 108%, from 12c per share.

06:32 EST Wabtec raises quarterly dividend 25%, announces $750M share buyback - Wabtec Board of Directors reauthorized a share buyback program up to $750M and declared a 25% increase in the regular quarterly common dividend to 5c payable on February 28 to holders of record on February 25.

06:16 EST Owens Corning sees FY22 capital additions $480M - Sees FY22 effective tax rate on adjusted earnings 25%-27%.

06:13 EST Similarweb to add mobile market data from App Annie into new product module - Similarweb announced a data licensing alliance with App Annie, a mobile data and analytics company. Under the agreement, Similarweb will license a set of App Annie's mobile application market data for incorporation into a new product module in Similarweb's product suite. The new product module will include essential mobile app metrics from App Annie, such as monthly active users, installed base, sessions, and more. Companies will be able to purchase web and mobile app market estimates from a single vendor, enabling them to get a holistic view of digital activity. The new offering is expected to be available in Q2.

06:09 EST Global Blood Therapeutics: EC grants marketing authorization for Oxbryta - Global Blood Therapeutics announced the European Commission has granted Marketing Authorization for Oxbryta for the treatment of hemolytic anemia due to sickle cell disease in adult and pediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide. Oxbryta, a once-daily, oral treatment, is the first medicine approved in Europe that directly inhibits sickle hemoglobin polymerization, the molecular basis of sickling and destruction of red blood cells in SCD.

06:08 EST SiteOne Landscape sees FY22 Adjusted EBITDA $430M-$450M - "While there is significant uncertainty associated with broad inflation and its effect on the U.S. economy in 2022, the current underlying trends for landscape maintenance, residential and commercial new construction, and residential repair and upgrade all remain positive," CEO Doug Black commented. "Additionally, we expect high product inflation to continue in the first half of 2022, moderating in the second half of the year. Taken together with our expectation to continue gaining market share, we would expect high single digit daily organic growth for the full year. We expect our gross margin to normalize this year without the substantial benefits that we saw in 2021 due to our strategic inventory purchases ahead of the rapid inflation. While we expect to mitigate some of this with SG&A leverage, we expect our overall Adjusted EBITDA margin to modestly decrease in 2022 but remain at a very healthy level as a foundation for further improvement in the years to come."

06:05 EST Barrick Gold announces $1B share repurchase plan - Barrick Gold announced that it plans to undertake a share repurchase program to allow for the buyback of some of its common shares. Barrick's board of directors has authorized a share repurchase program for the repurchase of up to $1B of the company's outstanding common shares over the next 12 months at prevailing market prices in accordance with applicable law.

06:03 EST Owens Corning announces additional 10M share repurchase program - On February 14, Owens Corning's Board of Directors approved a share repurchase authorization for up to 10M shares of the company's common stock. This was in addition to its previously announced share buyback program which had 3.4M shares available for repurchase under the prior authorization as of the end of 2021.

06:02 EST Hilton reports Q4 system-wide comparable RevPAR increased 104.2% - System-wide comparable RevPAR increased 104.2 percent and 60.4 percent, on a currency neutral basis, for the fourth quarter and full year, respectively, from the same periods in 2020. System-wide comparable RevPAR was down 13.5 percent and 30.0 percent, on a currency neutral basis, for the fourth quarter and full year, respectively, compared to the same periods in 2019. Approved 26,000 new rooms for development during the fourth quarter, bringing Hilton's development pipeline to 408,000 rooms as of December 31, 2021.

05:47 EST Avenue Therapeutics announces FDA committees vote against IV tramadol - Avenue Therapeutics announced the outcome of the FDA joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee on IV tramadol. In the final part of the public meeting, the advisory committee voted yes or no on the following question: "Has the Applicant submitted adequate information to support the position that the benefits of their product outweigh the risks for the management of acute pain severe enough to require an opioid analgesic in an inpatient setting?" The results are eight yes votes and 14 no votes. FDA Advisory Committees provide the FDA with independent advice and non-binding recommendations. The FDA has previously stated that input from an Advisory Committee is needed for the Office of New Drugs to reach a decision on Avenue's formal dispute resolution request and that the OND will respond to Avenue's FDRR within 30 calendar days after the Advisory Committee meeting.

05:26 EST Invitae announces FusionPlex Dx, LiquidPlex Dx availability in Europe - Invitae announced the availability of FusionPlex Dx and LiquidPlex Dx in Europe, part of its Anchored Multiplex PCR chemistry in-vitro diagnostic products.

05:19 EST Juniper collaborates with Vodafone, Parallel Wireless on multivendor RIC trial - Juniper (JNPR) announced that it is working with Vodafone (VOD) and Parallel Wireless conducting a multivendor RAN Intelligent Controller, or RIC, trial for tenant-aware admission control use cases. The trial, initially running in Vodafone's test labs in Turkey and with plans to move into its test infrastructure, supports O-RAN interfaces and addresses the business challenges faced by mobile operators around personalized user experience, viable revenue generation and reduction in both capex and opex for 4G and 5G services. The trial is based on an open, software-driven architecture that leverages virtualization to deliver more programmable, automated granular-by-user traffic management. The initial focus is on delivering tenant-aware admission control capability, enabling operators to personalize services and provide superior user experiences. The trial's design philosophy is focused on demonstrating the potential of enabling open, agile resource management and mobile data delivery in any software-driven RAN environment.